S&P 500
(0.02%) 5 071.63 points
Dow Jones
(-0.11%) 38 461 points
Nasdaq
(0.10%) 15 713 points
Oil
(-0.18%) $82.66
Gas
(0.91%) $1.668
Gold
(-0.38%) $2 329.50
Silver
(-0.44%) $27.23
Platinum
(-0.47%) $911.50
USD/EUR
(-0.05%) $0.934
USD/NOK
(0.03%) $10.99
USD/GBP
(0.00%) $0.802
USD/RUB
(0.02%) $92.34

Realtime updates for Yuyu Pharma, Inc. [000227.KS]

Exchange: KSC Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic
Last Updated24 Apr 2024 @ 20:30

-0.36% KRW 10 950

Live Chart Being Loaded With Signals

Commentary (24 Apr 2024 @ 20:30):

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants...

Stats
Today's Volume 22.00
Average Volume 2 310.00
Market Cap 76.98B
EPS KRW-40.79 ( 2022-09-30 )
Last Dividend KRW0 ( N/A )
Next Dividend KRW0 ( N/A )
P/E 0
ATR14 KRW64.84 (0.59%)

Yuyu Pharma, Inc. Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Yuyu Pharma, Inc. Financials

Annual 2023
Revenue: KRW137.21B
Gross Profit: KRW46.51B (33.89 %)
EPS: KRW-441.41
Q4 2023
Revenue: KRW34.61B
Gross Profit: KRW10.67B (30.82 %)
EPS: KRW-67.14
Q3 2023
Revenue: KRW34.09B
Gross Profit: KRW11.20B (32.87 %)
EPS: KRW-167.60
Q2 2023
Revenue: KRW34.22B
Gross Profit: KRW12.54B (36.66 %)
EPS: KRW-213.76

Financial Reports:

No articles found.

Yuyu Pharma, Inc.

Yuyu Pharma, Inc. develops and markets pharmaceutical products. The company offers various prescription drugs, including osteoporosis, brainbone metabolism-hypocalcemia improvement, cerebral and peripheral circulatory disturbance, tromboembolism, respiratory organ, hypertension, pulmonary tuberculosis therapy, arthrifuge, diabetic neuropathy therapy, eczematous dermatitis drugs, and other circulatory system drugs, as well as antibiotics and skeletal muscle relaxants. It also provides non-prescription drugs and health supplements. The company was formerly known as YuYu Inc. and changed its name to Yuyu Pharma, Inc. in May 2008. Yuyu Pharma, Inc. was founded in 1941 and is headquartered in Seoul, South Korea.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators